Current controversies in the management of breast cancer.
The following manuscript summarises the content of the Breast Symposium that was held in May 2008 in Barcelona in which four controversies regarding the management of breast cancer were discussed. The design of the symposium included two speakers per controversy, one in favour and one diverging, and the audience had to vote before and after the presentations to assess changes in the participants' views. The four controversies included: (1) the role of non-conventional predictive factors in selecting treatment for breast cancer; (2) the role of surgery in disseminated disease; (3) are taxanes indicated in the adjuvant treatment of patients with lymph-node-negative disease?; (4) is treatment with tamoxifen (TAM) always required after surgery in patients with ductal carcinoma in situ (DCIS)? The symposium concluded with the presentation titled: 'Features of a well designed clinical trial in the adjuvant treatment of breast cancer'.
Tusquets
I
I
Servicio de Oncología Médica, Unidad Funcional de Patología Mamaria, Hospital del Mar IMAS, Passeig Maritim, 25-29 Barcelona, Spain. itusquets@imas.imim.es
García-Estévez
L
L
Adrover
E
E
Calvo
L
L
Alvarez
I
I
García Mata
J
J
Fernández
Y
Y
Margueli
M
M
Seguí
M A
MA
Muñoz
M
M
Rodríguez
C
C
Rodríguez Lescure
A
A
Colomer
R
R
Gascón
P
P
Martín
M
M
Alba
E
E
Barnadas
A
A
Llombart
A
A
Albanell
J
J
Lluch
A
A
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008408:Mastectomy
D000970:Antineoplastic Agents
N Engl J Med. 2004 Dec 30;351(27):2817-26
15591335
J Clin Oncol. 2006 Aug 10;24(23):3726-34
16720680
J Clin Oncol. 2006 Jun 20;24(18):2743-9
16702580
Ann Surg Oncol. 2006 Jun;13(6):776-82
16614878
Cancer. 2004 Jan 1;100(1):28-35
14692021
Breast Cancer Res Treat. 2003 Feb;77(3):285-93
12602928
Ann Surg. 2008 May;247(5):732-8
18438108
J Clin Oncol. 2007 Sep 1;25(25):3871-6
17664457
Ann Surg Oncol. 2007 Aug;14(8):2187-94
17522944
J Natl Cancer Inst. 2007 Feb 21;99(4):272-82
17312304
J Clin Oncol. 1998 Feb;16(2):441-52
9469327
Lancet. 2003 Jul 12;362(9378):95-102
12867108
J Clin Oncol. 2007 Nov 1;25(31):4952-60
17971593
Eur J Cardiothorac Surg. 2002 Sep;22(3):335-44
12204720
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8315-20
15914550
J Clin Oncol. 2007 May 20;25(15):2127-32
17513820
J Natl Cancer Inst. 2007 May 2;99(9):727-37
17470740
Surgery. 2002 Oct;132(4):620-6; discussion 626-7
12407345
N Engl J Med. 2006 Aug 10;355(6):560-9
16899776
Cancer. 2007 Sep 1;110(5):973-9
17647245
J Clin Oncol. 2006 Dec 1;24(34):5381-7
17135639
J Clin Oncol. 2008 Feb 10;26(5):736-44
18258981
Lancet. 1999 Jun 12;353(9169):1993-2000
10376613
Ann Thorac Surg. 2005 May;79(5):1711-4; discussion 1714-5
15854960
Lancet. 2005 May 14-20;365(9472):1687-717
15894097
J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62
16288118
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1008-11
15824180
Nature. 2000 Aug 17;406(6797):747-52
10963602
Cancer. 2006 May 15;106(10):2104-12
16604564
Eur J Cancer. 2007 Feb;43(3):549-56
17140788
Eur J Cancer. 2001 Dec;37(18):2365-72
11720829
Eur J Cancer. 1995;31A(9):1425-7
7577065
Am J Surg. 2003 Feb;185(2):158-64
12559448
J Clin Oncol. 2008 Jan 1;26(1):44-53
18165639
Clin Cancer Res. 2007 Aug 15;13(16):4657-9
17699840
N Engl J Med. 1990 Feb 22;322(8):544-5
2405274
Clin Cancer Res. 2005 Aug 15;11(16):5678-85
16115903
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12963-8
12297621
JAMA. 2006 Apr 12;295(14):1658-67
16609087
Am J Surg. 2006 Oct;192(4):416-9
16978940
Breast Cancer Res Treat. 2008 Mar;108(2):183-90
17468948
Ann Surg. 2006 Dec;244(6):897-907; discussion 907-8
17122615
Health Technol Assess. 2007 Oct;11(40):1-144
17903394
J Clin Oncol. 2008 Feb 20;26(6):925-33
18281666
Ann Oncol. 2006 Aug;17(8):1205-12
16766587
J Natl Cancer Inst. 2007 Feb 7;99(3):196-205
17284714
N Engl J Med. 2007 Oct 11;357(15):1496-506
17928597
J Natl Cancer Inst. 2007 Feb 21;99(4):283-90
17312305